Chief Scientific Officer
Dr Bernard Ng is a medical and clinical affairs leader with global, regional and local experience in Pharmaceutical and Consumer Health industry.
He was previously the Vice President, Head of Global Medical & Clinical Affairs for Bayer Consumer Healthcare. He is an active proponent of leveraging digital technologies and data to create disproportionate value for healthcare professionals, patients and consumers.
Dr Ng obtained his Doctor of Medicine from the National University of Malaysia and his MBA from the University of Melbourne. He is a strong believer of the Disruptive Strategy model by the Clayton Christensen from Harvard Business School.
He also was in IMD, Lausanne for a digital transformation course to better understand the disruptive power of platforms in today’s competitive environment.